Advertisement

Topics

PellePharm closes $20mm Series B round

15:40 EDT 3 Aug 2017 | Elsevier Business Intelligence

PellePharm Inc. (oncology) raised $20mm through a three-tranche Series B round that was led by BridgeBio Pharma.

Original Article: PellePharm closes $20mm Series B round

NEXT ARTICLE

More From BioPortfolio on "PellePharm closes $20mm Series B round"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...